Radiation therapy for prostate cancer is more precise, convenient, and personalized than ever before. From #SBRT to MRI-guided and adaptive approaches, MSK experts are leading advances that improve outcomes and protect quality of life for patients with #prostatecancer. ⬇️

Cancer research means bigger breakthroughs, on a faster timeline, that improve the lives of people impacted by cancer. Today is World Cancer Research Day & all donations will be DOUBLED. Donate today & help bring more possibilities to families facing cancer. bit.ly/46mefYy #WorldCancerResearchDay

ATG16L strikes again! New findings link #lysosome stress and physiology. Alison Klein and Michael Overholtzer @mskcancercenter.bsky.social discuss new study from @thabataduque.bsky.social et al. of the Deretic group (rupress.org/jcb/article/...) in Spotlight: rupress.org/jcb/article/...

🎥 At #SOHO2025, Ariela Noy of @mskcancercenter.bsky.social shared insights into the management of Burkitt #lymphoma, highlighting the need to improve frontline treatment. Watch here: 👉 buff.ly/kp1MrVH 👈 #LYMsm #Lymphoma #HemOnc #BloodSky #HemeSky #MedSky @societyofhemonc.bsky.social

Join us for MSK's 2025 Health Equity in Cancer Care Conference on Friday, November 14. This complimentary one-day event will unite experts from across fields, institutions, and specialties to explore actionable strategies for advancing #healthequity in underserved populations.

Coming up at #IMS25: Join MSK's Myeloma Service Chief @szusmani.bsky.social to learn about current challenges in #multiplemyeloma relapse & future research needed to overcome them. #mmsm 🗓️ Friday, September 19 | 9:40 a.m. EDT @mskcancercenter.bsky.social @myeloma-society.bsky.social

Coming up at #IMS25: Dr. Sham Mailankody will share the results of a phase 1 clinical trial of concurrent BCMA and GPRC5D #CARTcells for relapsed/refractory #multiplemyeloma. 🗓️ Thursday, September 18 | 4:40 p.m. EDT @mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social

New research from MSK shows the Make-an-IMPACT program, a tumor test developed at MSK, improves global access to #genomic testing in #pediatric cancer patients.

Join the MSK Department of Radiation Oncology at their booth (#3306) during ASTRO from September 27-October 1. #ASTRO25 #radiationoncology

At #IMS25, Dr. Carlyn Tan will share new data on early mortality associated with real-world bispecific antibody therapy for relapsed/refractory #multiplemyeloma. 🗓️ Wednesday, September 17 | 12:14 p.m. EDT @mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social

congratulations to our DB colleague Maria Jasin, recognized by the Greengard Prize! when she started her lab @mskcancercenter.bsky.social, she was the first to insert DNA into a defined location of a mammalian genome! her work underlies today's CRISPR-mediated HDR. here in convo with Rick Lifton.🧬

MSK experts have arrived at #IMS25! Join Dr. Francesco Maura to learn about genomic drivers of resistance to anti-BCMA immunotherapies in #multiplemyeloma. #mmsm 🗓️ Wednesday, September 17 | 11:10 a.m. EDT @mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social

As part of our National Postdoc Appreciation Week tradition, we are celebrating our remarkable #MSKPostdocs with social cards & profiles! 🎉🙌 Stay tuned over the next two weeks to meet the outstanding scientists driving innovation at @mskcancercenter.bsky.social💡🧬🥼👩‍🔬👨‍🔬 #NPAW2025

In @jcb.org, Klein and Overholtzer @mskcancercenter.bsky.social discuss new findings from the Deretic group (@thabataduque.bsky.social et al. rupress.org/jcb/article/...) showing ATG16L, a regulator of lysosomal stress responses, has a day job regulating the v-ATPase. rupress.org/jcb/article/...

🥇 & 🏆people's choice goes to Brendan Camellato from the lab @choijunhong.bsky.social lab 🥈 @meganekelley.bsky.social from the @agnelsfeir.bsky.social lab 🥉 @arthurwchow.bsky.social from the @caleblareau.bsky.social lab

🎉 Congratulations to our 10 MSK Postdoc Slam finalists! 👏 You were all fantastic and it was truly inspiring to learn about the incredible and diverse work happening at @mskcancercenter.bsky.social. Our #MSKPostdocs gave the judges a real challenge… choosing winners was no easy task! 🤗 #NPAW2025

A few MSK Postdocs present during our Postdoc Slam. #PostdocAppreciationWeek

Reporting live from MSK's Postdoc Slam during #PostdocAppreciationWeek. @mskeducation.bsky.social

It’s SHOW TIME! 🎤 Kicking off the MSK Postdoc Slam is @meganekelley.bsky.social from the @agnelsfeir.bsky.social lab, diving into how error-prone DNA repair fuels drug resistance in cancer 🧬💊

Thrilled to announce the upcoming Center for Epigenetic Research Symposium @mskcancercenter.bsky.social on Nov 17! 🎉 A full day of cutting-edge science featuring stellar external speakers & our outstanding trainees. Registration is now open! Join us in NYC or virtually from anywhere! link⬇️

MSK is headed to Toronto for #IMS25! Stay tuned for posters and presentations that are advancing #multiplemyeloma research and treatments. #mmsm @mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social

Happy National Postdoc Appreciation Week to our phenomenal #MSKPostdocs! @mskcancercenter.bsky.social community, join us today @ 4pm for the Postdoc Slam competition. We will also announce the winners of the 📸 contest and have some extra surprises for you all 😊🫢 #NPAW2025

DYK: 76% of MSK postdoctoral researchers are international, coming from more than 60 countries for training and mentorship that translates into scientific discoveries across the globe? 🌎 Learn more about our incredible MSK postdocs: #PostdocAppreciationWeek

Starting TODAY! Join @greatdebates.bsky.social and Yelena Janjigian, Chief of the MSK Gastrointestinal Oncology Service, to learn about the latest treatments for #gastriccancer and #colorectalcancer. @mskcancercenter.bsky.social #crcsm #GIcancer See the full agenda 📖: bit.ly/48g13pf

Sign up to read exclusive expert insights on key abstracts to watch at #IMS25! @szusmani.bsky.social @mskcancercenter.bsky.social @myeloma-society.bsky.social #mmsm www.onclive.com/view/experts...

🚨 Happening Soon: @mskcancercenter.bsky.social's Eileen O'Reilly and @mayocliniccancer.bsky.social's Tanios Bekaii-Saab will kick off #ISGIO2025! Join them for opening remarks as program chairs at 9 a.m. CDT/10 a.m. EDT. #GICSM See the agenda for a full lineup of MSK experts: bit.ly/3JSTg6V

MSK experts are pioneering innovative ways to treat #throatcancer that aim to give people better outcomes while preserving their appearance and the functions of the throat.

🎉 Congrats to MSK's most recent Awards & Appointments honorees, including Dr. Matthew Bott joining the @lcrf.org Scientific Advisory Board and Dr. Martin Weiser, Dr. Julio Garcia-Aguilar, and Dr. Emmanouil Pappou for being named 2025 America’s Leading Doctors in Colorectal Surgery by @newsweek.com.

Happening Tuesday, 9/9 at #WCLC25: MSK's Dr. David Jones will discuss perioperative modalities for resectable non small cell #lungcancer. Follow along for coverage of the latest advances. #LCSM #SCLC @iaslc.bsky.social l Tuesday, 9/9 | 1 p.m. CEST Learn more: bit.ly/3V3O8iD

Happening Tuesday, 9/9 at #WCLC25: MSK's Dr. Alexis Chidi will discuss how deep learning-based CT analysis enhances #lungcancer risk prediction in never smoking women. Follow along for coverage of the latest advances. #LCSM #SCLC @iaslc.bsky.social Tuesday, 9/9 | 10 a.m. CEST More: bit.ly/45XeCZq

Tomorrow morning, #lungcancer expert Mark Kris will discuss clinicopathologic features of TP53/RB1-mutant squamous cell lung cancers at #WCLC25. #LCSM @iaslc.bsky.social @mskcancercenter.bsky.social September 8 | 10:30 a.m.. CEST ➡️ bit.ly/41EZM7b

Zidesamtinib Data Align With Clinical Expectations in Pretreated ROS1+ Advanced NSCLC @iaslc.bsky.social @mskcancercenter.bsky.social #WCLC25 #lcsm #oncology www.onclive.com/view/zidesam...

MSK’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences is now accepting applications for its Cancer Biology and Cancer Engineering #PhD programs for the 2026 academic year. Apply below:

Don't miss an opportunity to learn from the Chief of the Thoracic Oncology Service at @mskcancercenter.bsky.social! At #WCLC25, Mark Awad will share lessons about work-life balance in high-stress medical careers. #LCSM @iaslc.bsky.social September 7 | 1:45 p.m. CEST ➡️ bit.ly/3HTNpxr

Coming up at #WCLC25: @mskcancercenter.bsky.social's Helena Yu will highlight diagnostic and treatment opportunities for #leptomeningealdisease in oncogene-driven non-small cell #lungcancer. #LCSM @iaslc.bsky.social September 7 | 3:53 p.m. CEST ➡️ bit.ly/4mOHBnV

Happening Monday, 9/8 at #WCLC25: MSK pathologist Dr. Natasha Rekhtman will discuss optimizing front-line treatment for small cell #lung cancer. Follow along for coverage of the latest advances. #LCSM #SCLC @iaslc.bsky.social 📆: September 8 at 5 p.m. CEST Learn more: bit.ly/4mXBiig

Dr. Young Hun Kim shares her experience establishing and operating FluidFM at the Molecular Cytology Core Facility during her time at @mskcancercenter.bsky.social 👇🎬

Happening tomorrow at #WCLC25: @mskcancercenter.bsky.social's @charlesrudin.bsky.social will highlight future directions in small cell #lungcancer research. Follow along for coverage of the latest advances. #LCSM #SCLC @iaslc.bsky.social September 6 | 10:30 a.m. CEST ➡️ bit.ly/3HJJmnp

Out now in @cp-trendsbiochem.bsky.social: "PTMs as Molecular Encoders: Reprogramming Chaperones into Epichaperomes for Network Control in Disease" from @chiosislabmskcc.bsky.social. Learn more ⬇️

🌟Very excited to share that our article 'PTMs as Molecular Encoders: Reprogramming Chaperones into Epichaperomes for Network Control in Disease' is out online now in @cp-trendsbiochem.bsky.social #PTMs #HSP90 #epichaperome #PPI #neuroscience @mskcancercenter.bsky.social doi.org/10.1016/j.ti...

Results of a pilot study led by investigators at @mskcancercenter.bsky.social showed that interleukin-18 “armored” CAR T cells targeting CD371 were effective at treating relapsed/refractory acute myeloid #leukemia at low doses. @markgeyermd.bsky.social Learn more: bit.ly/4mFwo9q

At MSK, Clinical Nurse Specialists (CNS) are making a significant impact on patient outcomes through their expert guidance, evidence-based interventions, & compassionate leadership. This #CNSWeek, we honor their dedication to advancing care and improving lives. Help celebrate our MSK CNSs below! 🎉

Congrats to Rastko Rakočević of the Pulmonary Service on receiving a certificate of excellence for presenting a top abstract in a plenary session at #AABIP2025! He presented research on robotic-assisted #bronchoscopy for biopsy of primary #lungcancers. @mskcancercenter.bsky.social

Breast medical oncologist and early drug development specialist @breastcancerdoc.bsky.social discusses how molecular subtyping, antibody-drug conjugates, and precision trials are reshaping the field of #breastcancer on @emjreviews.bsky.social lastest podcast. 🎙️ Listen here: bit.ly/422CWXd

A new study by @ludwigcancer.bsky.social Oxford and @mskcancercenter.bsky.social has shown that the mechanical environment surrounding #tumours cause behavioural changes in #cancer cells. Their results offer new information for creating cancer treatments in the future. Read more 👉 buff.ly/09AkKx2

New FDA-approved blood test "Shield" offers a less invasive #colorectal cancer screening, but while Shield may detect later-stage cancers, it misses over one-third of stage 1 cancers and most precancerous polyps. Learn more about what MSK experts have to say about Shield. ⬇️ #cansky

An agonist anti-CD40 with enhanced binding to FcγRIIB showed early promise in a small cohort of patients with metastatic melanoma. Read our digest here 👉 bit.ly/4nc91nR  @juanosoriomd.bsky.social‬  @mskcancercenter.bsky.social‬

www.youtube.com/watch?v=7JOT... Found this great video of #DrMichaelPostow explaining potential of predicting #immunotherapy response with imaging! @mskcancercenter.bsky.social #ShortTakesInOncology #peer2peermd

MSK researchers are working to develop blood tests for #cancer, known as "liquid biopsies,” to detect early-stage cancer prior to the onset of symptoms. Such tests are already used to diagnose and monitor people with cancer. Learn more ⬇️

Introducing a new, high-yield CME program @mskcancercenter.bsky.social designed to streamline preparation for the ABIM certification & recertification exams in Medical Oncology. Registration is complimentary for all fellows. Learn more: bit.ly/MedOncReview2025 #MSKAcceleratedMedOncReview